Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13070334 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL19277005 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL18934170 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL20880901 | 0.85 | TDP1 (0.31) | TDP1 | |
| SCHEMBL19308712 | 0.83 | TDP1 (0.36) | TDP1TSHR | |
| SCHEMBL24316732 | 0.82 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL2305046 | 0.82 | TDP1 (0.44) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL15966302 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL16729464 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL19592300 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11241507-B2 | Near-infrared chemiluminescent probes for in-vivo imaging | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-02-08 | — | — | US | disclosed |
| US-9969762-B2 | Method for synthesizing N-alkyl-glycosyl(di)amine derivatives and uses of same against phytopathogens | SIPRE (FR) | 2018-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11241507-B2 | Near-infrared chemiluminescent probes for in-vivo imaging | DHPS, DOHH, DAZAP1 | TDP1 1475/4885LMNA 2005/4885L3MBTL1 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.